Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin vs Norfloxacin for SBP Prophylaxis in Cirrhosis
NCT03695705Phase 3Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jan 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rifaximin in spontaneous bacterial peritonitis (SBP), sponsored by Post Graduate Institute of Medical Education and Research. Started Jan 2016; status: completed.
02
Drugs
rifaximin
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT03695705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03695705.